REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 18th, 2016 • BioPharmX Corp • Pharmaceutical preparations • Delaware
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of August 12, 2016 by and among BioPharmX Corporation (the “Company”) and each of the persons or entities listed on Schedule I attached hereto (each of them, a “Purchaser” and, collectively, the “Purchasers” and, together with the Company, the “Parties”).
PURCHASE AGREEMENTPurchase Agreement • August 18th, 2016 • BioPharmX Corp • Pharmaceutical preparations • Delaware
This PURCHASE AGREEMENT dated as of August 12, 2016 (this “Agreement”) is by and among BioPharmX Corporation (the “Company”) and each of the persons or entities listed on Schedule I attached hereto (each of them, a “Purchaser” and, collectively, the “Purchasers” and, together with the Company, the “Parties”).
SUBSCRIPTION AGREEMENTSubscription Agreement • August 18th, 2016 • BioPharmX Corp • Pharmaceutical preparations • Delaware
The undersigned (the “Investor”) hereby confirms its agreement to the terms of this Subscription Agreement (“Agreement”) with BioPharmX Corporation, a Delaware corporation (the “Company”), as follows:
STANDSTILL AGREEMENTStandstill Agreement • August 18th, 2016 • BioPharmX Corp • Pharmaceutical preparations • Delaware
This STANDSTILL AGREEMENT (this “Agreement”) dated August 12, 2016, is by and among BioPharmX Corporation (the “Company”) and each of the persons or entities listed on Schedule I attached hereto (each of them, a “Purchaser” and, collectively, the “Purchasers”).
BIOPHARMX CORPORATIONPurchase Agreement • August 18th, 2016 • BioPharmX Corp • Pharmaceutical preparations
Reference is made in this letter agreement (this “Letter Agreement”) to that certain Purchase Agreement dated as of December 9, 2015 (the “Purchase Agreement”), by and between BioPharmX Corporation (the “Company”) and Franklin Strategic Series - Franklin Biotechnology Discovery Fund (the “US Purchaser”) and Franklin Templeton Investment Funds — Franklin Biotechnology Discovery Fund (the “SICAV Purchaser” and, together with the US Purchaser, the “Purchasers”, and each of them, a “Purchaser”). Capitalized terms used herein and not otherwise defined shall have the meaning given to those terms in the Purchase Agreement.
SECURITY AGREEMENTSecurity Agreement • August 18th, 2016 • BioPharmX Corp • Pharmaceutical preparations • California
This SECURITY AGREEMENT (“Agreement”), is made effective as of August 17, 2016 (this “Agreement”), by and among BioPharmX Corporation, a Delaware corporation (the “Company”), each of the persons executing a copy of this Agreement, and their respective successors and assigns (each an “Investor” and, collectively, the “Investors”), and RTW Master Fund, LTD as collateral agent for the Investors (in such capacity, the “Collateral Agent”).
